Evidence for anti-inflammatory activity of statins and PPARalpha activators in human C-reactive protein transgenic mice in vivo and in cultured human hepatocytes in vitro.
about
Role of lipotoxicity in endothelial dysfunctionA novel therapeutic effect of statins on nephrogenic diabetes insipidusRepurposing Treatments to Enhance Innate Immunity. Can Statins Improve Neutrophil Functions and Clinical Outcomes in COPD?Peroxisome proliferators-activated alpha agonist treatment ameliorates hepatic damage in rats with obstructive jaundice: an experimental study.Atorvastatin improves plaque stability in ApoE-knockout mice by regulating chemokines and chemokine receptors.Effects of atorvastatin on human C-reactive protein metabolism.A systems biology strategy for predicting similarities and differences of drug effects: evidence for drug-specific modulation of inflammation in atherosclerosis.Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels.Statins, the renin-angiotensin-aldosterone system and hypertension - a tale of another beneficial effect of statins.A clinical evaluation of statin pleiotropy: statins selectively and dose-dependently reduce vascular inflammationA dietary mixture containing fish oil, resveratrol, lycopene, catechins, and vitamins E and C reduces atherosclerosis in transgenic mice.Impact of genetic and environmental factors on hsCRP concentrations and response to therapeutic agentsInfluence of statin use on the incidence of recurrent venous thromboembolism and major bleeding in patients receiving rivaroxaban or standard anticoagulant therapyLipid-lowering drug use is associated with reduced prevalence of atrial fibrillation in patients with left ventricular systolic dysfunction.Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromataThe connection between C-reactive protein and atherosclerosisPPARalpha in atherosclerosis and inflammation.Atorvastatin Reduces the Survival of Candida albicans-Infected BALB/c Mice.New anti-inflammatory agents to reduce atherosclerosis.Statins as first-line therapy for acute coronary syndrome?PPARs and molecular mechanisms of transrepressionCardiovascular actions of the peroxisome proliferator-activated receptor-alpha (PPARalpha) agonist Wy14,643.Vascular and metabolic effects of treatment of combined hyperlipidemia: focus on statins and fibrates.Down-regulation of transcription factor peroxisome proliferator-activated receptor in programmed hepatic lipid dysregulation and inflammation in intrauterine growth-restricted offspring.The Role of NF-kappaB in PPARalpha-Mediated Hepatocarcinogenesis.Effects of three different fibrates on intrahepatic cholestasis experimentally induced in rats.Seasonal and sex variation of high-sensitivity C-reactive protein in healthy adults: a longitudinal study.Renal and liver tumors in Tsc2(+/-) mice, a model of tuberous sclerosis complex, do not respond to treatment with atorvastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor.MIF deficiency reduces chronic inflammation in white adipose tissue and impairs the development of insulin resistance, glucose intolerance, and associated atherosclerotic disease.Statins and nitric oxide reduce C-reactive protein production while inflammatory conditions persistDifferential metabolic effects of pravastatin and simvastatin in hypercholesterolemic patients.Therapeutic potential of phosphoethanolamine-bound C-reactive protein in atherosclerosis.Acylcarnitine profiles in acetaminophen toxicity in the mouse: comparison to toxicity, metabolism and hepatocyte regeneration.Pharmacotherapy of coronary atherosclerosis.Regulation of human hepatic drug transporter expression by pro-inflammatory cytokines.Beneficial effects of cocoa on lipid peroxidation and inflammatory markers in type 2 diabetic patients and investigation of probable interactions of cocoa active ingredients with prostaglandin synthase-2 (PTGS-2/COX-2) using virtual analysisAssessment of immunotoxicity using precision-cut tissue slices.Use of nutrigenomics endpoints in dietary interventions.Simvastatin impairs murine melanoma growth.Attenuation of Proinflammatory Responses by S-[6]-Gingerol via Inhibition of ROS/NF-Kappa B/COX2 Activation in HuH7 Cells.
P2860
Q27000731-0D826BD1-DB9F-497C-926B-DEBD75387736Q27005638-D9B00D2D-1BBF-4D73-8042-FE4BBF9BEA95Q28066773-B1CE1393-623F-4D65-887B-F600F932E099Q33307635-D088C48F-4A8D-4468-B750-75A75EA45717Q33591205-E8E79813-24CC-4E5E-919A-13FE34DBA5ADQ33848035-AB464582-8903-4BF0-98F2-FABDF396BCC0Q33991958-FF035CBE-07D1-4803-A506-C7779127B7B3Q34021076-CB828684-C1E1-41FA-9F6B-0A142E226762Q34429685-1617DBC3-9A87-446D-A1A8-CF6329FAA890Q34562390-0D525EA5-0728-4978-927B-8887E4FC971DQ34802107-6E516402-9BDC-45CA-B282-E9F1F3127644Q34901492-F2C82209-31C6-466A-8CFB-FD6B0081CA67Q35101273-2D7D8057-C697-4EF2-8358-5D741ADE926DQ35187745-F3692082-6DC3-4FCE-B94D-7D8F9631D9E6Q35251005-2176EBD7-F67C-4355-9491-6A705385C9BFQ35999439-4C2B8CCF-7230-452A-9E0B-10224109FFE9Q36154953-148A5735-3298-4433-9573-AAD61810E55EQ36392153-FA9A23D5-D481-4749-B439-685C00DE6D93Q36576558-18F33715-422E-4CAB-BAF1-47215CB13011Q36768488-EA642916-EDD7-497A-A121-7ED3ABFDCAF8Q36791361-33EC173E-DAD9-4674-BE36-CAA61FA26E0FQ36872068-DC5D5925-A99C-4BAD-9FA3-9532A0011E80Q36894180-AFEFC020-3008-4C78-A44F-D58FCAAAB3D3Q37001637-AABCFF1F-46F5-4434-B9AD-55B70B9396D8Q37078825-E385D6AD-8AE6-40AE-A022-D671D478AFB5Q37122494-3E31FD53-D10A-4E0F-BDAA-6CB42A8F5738Q37252436-D1EDB458-EA74-4BD5-AC0A-53444DFA90DAQ37267573-541E0628-58B9-4484-87E5-B91A822C8FC5Q37280881-02014A77-F883-4329-AF12-9B724D2F2507Q37281358-399E8FE7-CCD5-4E16-A930-9E34B05B9886Q37362218-5D4750A6-49AD-45FF-B252-70CD4AD41DFAQ37406470-D2AAEE1C-8B3F-4479-85BF-A7E61976BAAAQ37512777-4ACA6869-B56E-4DAA-9F0F-8DE94BF00931Q37519710-81FF8814-700A-4D9B-830F-CB7645EDE60FQ37604385-D35A99A1-1F2A-4413-8E43-760E437FA51AQ37717491-54C8D868-4122-431C-A632-201E7B1F25EFQ38063965-2C8D6D35-08D5-40A1-A6C7-9435AD68E2DCQ38109666-39D3BAD9-ED11-405B-A569-5F1088C6BFE4Q39619441-FDF0F9B5-9402-47E5-B898-C1A97DCF00B7Q41446741-68051FB5-BBBF-4211-889D-AAF08A1E97D3
P2860
Evidence for anti-inflammatory activity of statins and PPARalpha activators in human C-reactive protein transgenic mice in vivo and in cultured human hepatocytes in vitro.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Evidence for anti-inflammatory ...... ed human hepatocytes in vitro.
@en
type
label
Evidence for anti-inflammatory ...... ed human hepatocytes in vitro.
@en
prefLabel
Evidence for anti-inflammatory ...... ed human hepatocytes in vitro.
@en
P2093
P1433
P1476
Evidence for anti-inflammatory ...... ed human hepatocytes in vitro.
@en
P2093
Alexander J Szalai
Bert-Jan de Rooij
Hans M G Princen
Jan Lindeman
Lars Verschuren
Moniek M de Maat
Robert Kleemann
Teake Kooistra
P304
P356
10.1182/BLOOD-2003-11-3791
P407
P577
2004-02-19T00:00:00Z